Pure Health Holding Pjsc · ADX:PUREHEALTH
Pure Health Holding Pjsc — PureHealth — 9M 2024 Earnings Presentation
27 slides from Pure Health Holding Pjsc's earnings presentation, Sep 30, 2024
Slide 1: Earnings Presentation 9M 2024
EARNINGS PRESENTATION 9M 2024
Slide 2: Strong 9M 2024 performance driven by organic growth and strategic acquisitions
Strong 9M 2024 performance driven by organic growth and strategic acquisitions Total Revenue 9M 2024 EBITDA 9M 2024 Net Profit 9M 2024 3,126 +26% 1,436 +13% +56% AED Million YoY AED Million YoY YoY EBITDA Margin Net Profit Margin 18,956 AED Million 16.5% 7.6% Figures and percentages in this document
Slide 3: Highlights of our performance across key segments on YoY basis
Highlights of our performance across key segments on YoY basis Growth % are for 9M’24 vs 9M’23 Hospital and Other Related Health Insurance Procurement and Supply of Diagnostic Services Services* Services Medical related products Total Patient Test Volume Interactions 7 Mn+ +66% Members +4% (Non-Covi
Slide 4: PureHealth - Our Global Footprint
PureHealth - Our Global Footprint Middle East’s Largest Group 24,000+ 24 60 Hospitals Pharmacies Employees UAE 143+ 50 M+ 3 M+ Laboratories Claims Members insured USA’s 4th Largest Private Group 24,000+ 30+ 06 Employees Hospitals States USA 200+ 1,700+ Sites of Care Providers UK’s Largest 9,000+ 50+
Slide 5: Building a diversified portfolio across multiple jurisdictions
PureHealth is building a diversified portfolio across multiple jurisdictions through strategic initiatives and realized opportunities Key Highlights for 9M 2024 Circle Health Group was SSMC was announced as a IP & ED services started at named the UK’s Top Private Centre of Excellence for Burn Sheikh
Slide 6: Building a diversified portfolio across multiple jurisdictions
PureHealth is building a diversified portfolio across multiple jurisdictions through strategic initiatives and realized opportunities Key Highlights for 9M 2024 Sheikh Khalifa Hospital Fujairah expanded services by Monthly volumes from Weekend / Sunset clinics at PureLab Expanded Operations starting
Slide 7: PureHealth Group includes well recognized brands
PureHealth Group includes well recognized brands PureHealth recognized as a powerhouse with a brand value exceeding USD 2 billion by Brand Finance MOST VALUABLE 4TH STRONGEST UAE 6TH STRONGEST UAE HEALTHCARE BRAND BRAND BRAND 2024 ACROSS ALL SECTORS ACROSS ALL SECTORS 2024 2024 PureHealth Earnings P
Slide 8: We create value through Sustainability and Social Impact
We create value through Sustainability and Social Impact SUSTAINABILITY PERFORMANCE SNAPSHOT | 2023 First and only Healthcare entity in > 13% AED 35M MENA region to set Net Zero by 2040 SBTi aligned target PureHealth launched its inaugural Sustainability Report for 2023 in Sep 2024. REDUCTIONS IN IN
Slide 9: Some of our forward-looking initiatives include
Some of our forward-looking initiatives include…. Strategic Priorities Forward Looking Initiatives • Position for both domestic and international expansion. Region’s Largest Reference UAE’s First Longevity Clinic Laboratory • Capitalize on the growing demand for high-quality integrated healthcare se
Slide 10: Financial Review
+ PURYHYALTH 9M 2024 Financial Review
Slide 11: The Group's financial performance was enhanced by expansion across all segments
The Group’s financial performance was enhanced by expansion across all segments AED Mn 9M 2024 9M 2023 Δ% 3Q 2024 3Q 2023 Δ% Net Profit Movement YoY (AED Mn) Revenue 18,956 12,117 +56% 6,452 3,967 +63% 9M 2024 Cost of sales (13,548) (9,454) +43% (4,416) (3,044) +45% Gross profit 5,408 2,663 +103% 2,
Slide 12: Revenue growth of 56% YoY is driven by solid performance across segments
Revenue growth of 56% YoY is driven by solid performance across business segments Revenue (AED Mn) 3Q 2024 Total Revenue Movement YoY (AED Mn) 9M 2024 +56% +63% 727 867 (28) 246 (1,732) 6,115 6,388 6,452 6,760 18,956 12,117 3,967 4,282 +87% +17% +29% -4% 100% 46% +8% +43% +4% +1% 9M 23 Hospitals and
Slide 13: Overall OPEX increased by 55% YoY in 9M 2024
Overall OPEX increased by 55% YoY in 9M 2024, driven by recent acquisitions and strong organic growth Total OPEX Movement YoY (AED Mn) Total OPEX Movement by segments YoY (AED Mn) 9M 2024 9M 2024 +55% +55% 2,014 17,134 565 39 832 223 (1,828) 4,094 6,275 17,134 11,026 11,026 100% 53% +89% +14% +8% +2
Slide 14: Group EBITDA rose 26% YoY to AED 3.1 bn
Group EBITDA rose 26% YoY to AED 3.1 bn, achieving a 16.5% margin in 9M 2024 EBITDA Movement by segments (AED Mn) 9M 2024 EBITDA Margin (%) 9M 2024 +26% 20.5% 335 206 (57) 40 30 85 3,126 2,487 17.7% 17.2% 16.5% 14.9% 100% -45% +18% +60% -19% +24% 9M 23 Hospitals and Health Diagnostic Procurement Tec
Slide 15: Robust balance sheet fueled by strategic asset growth
Robust balance sheet fueled by strategic asset growth Total Assets (AED BN) Total Equity (AED Bn) 48.4 +72% 19.3 +20% vs Dec 23 vs Dec 23 Cash & Bank Balance (AED Bn) Right of Use Assets (AED Bn) Total Bank Debt (AED Bn) Total Liabilities (AED Bn) 8.7 11.3 1.9 29.1 Total Assets Movement (AED Bn) 9M
Slide 16: Leverage position increased, primarily driven by higher bank debt
Leverage position increased, primarily driven by higher bank debt in the 9M 24 period 9M 2024 Debt for Circle Acquisition Total Bank Debt to Equity Total Bank Debt (AED Bn) +546% 1,845 0.1x 2.1 1.9 1.9 0.3 0.3 AED M 9M 2024 -0% +639% -13% +1% Maturity: Annual % Rate: 9M 23 FY 23 1Q 24 1H 24 9M 24 Ja
Slide 17: Operating and investing activities drive cash movements in 9M 2024
Operating and investing activities drive cash movements in 9M 2024 AED Mn 9M 2024 9M 2023 Δ% Cash & Cash Equivalents Movement (AED Mn) 9M 2024 Net Profit for the period before tax 1,528 1,701 -10% Non-cash Adjustments 1,764 749 +136% -26% Working Capital Changes (2,521)* (1,603)* +57% Employees’ end
Slide 18: Significant increase in net cash due to acquisitions
Significant increase in net cash due to acquisitions AED Mn 9M 2024 9M 2023 Trade and Other Receivables Movement (AED Mn) 9M 2024 EBITDA 3,126 2,487 +89% Change in Net Working Capital* (2,521) (1,603) Other operating activities 807 (804) 2,069 (297) 33 8,848 2,362 Maintenance CAPEX (492) (303) 4,681
Slide 19: Medium-term financial outlook and operational objectives
Medium-term financial outlook and operational objectives Medium-Term Target FY 2023 9M 2024 Achievement (2024-2028) Revenue growth (vs prior period) +31% +56% Mid- to High-teens International business as % of 0% 18.4% c.50% Revenue* EBITDA margin 14.9% 16.5% Low 20s CAPEX as % of Revenue 2.7% 3.4% <
Slide 20: Segment Performance Review
9M 2024 Segment Performance Review
Slide 21: Hospital and Other Related Services
Hospital and Other Related Services: A diverse healthcare portfolio, led by SEHA, with a focus on global expansion and strategic growth Total Revenue (AED MN) Gross Profit (AED MN) EBITDA (AED MN) Net Profit (AED MN) 14,569 +87% 4,781 +86% 2,199 +18% 808 -43% YoY YoY YoY YoY 15.1% EBITDA margin 5.5%
Slide 22: PureHealth continues to expand its footprint locally and globally
PureHealth continues to expand its footprint locally and globally, driving growth through strategic initiatives Private provider in the UK, provides Incremental №1 access to attractive and growing 58K+ Outpatient Volumes UK healthcare market 732 Beds 400K+ Patient 3,000+ 718 Beds within Al Ain Regio
Slide 23: Health Insurance Services: Daman is the largest health insurance provider in the UAE
Health Insurance Services: Daman is the largest health insurance provider in the UAE Total Revenue (AED MN) Gross Profit (AED MN) EBITDA (AED MN) Net Profit (AED MN) 5,053 +17% 629 +50% 548 +60% 451 +60% YoY YoY YoY YoY 8.9% Net Profit margin 10.8% EBITDA margin Return on Investments 7.4% +2.1bps (Y
Slide 24: Procurement and Supply of Medical Related Products
Procurement and Supply of Medical Related Products Total Revenue (AED MN) Gross Profit (AED MN) EBITDA (AED MN) Net Profit (AED MN) 3,858 +29% 325 +23% 209 +24% 172 +11% YoY YoY YoY YoY 5.4% EBITDA margin 4.5% Net Profit margin Business Partnerships AED 3.3Bn Total Procurement Spend 800+ Delivery po
Slide 25: Diagnostic Services: UAE's Largest Lab Network
Diagnostic Services: UAE’s Largest Lab Network Total Revenue (AED MN) Gross Profit (AED MN) EBITDA (AED MN) Net Profit (AED MN) 725 -4% 333 -1% 243 -19% 183 -34% YoY YoY YoY YoY 33.6% EBITDA margin 25.2% Net Profit margin Business Expansion: • Adding in new clientele including partnerships on an int
Slide 26: Technology Services and Others
Technology Services and Others: Accelerating digital services by providing solutions across the healthcare ecosystem Total Revenue (AED MN) Gross Profit (AED MN) EBITDA (AED MN) Net Profit (AED MN) 246 51 30 20 12.4% EBITDA margin 8.0% Net Profit margin • PureNet, a digital health-as-a-service platf
Slide 27: PureHealth Investor Relations
Thank you for attending! Should you have any questions or queries, please reach out. PureHealth Investor Relations https://purehealth.ae/investor-relations/ ir@purehealth.ae